id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-E-4696-0009,FDA,FDA-2015-E-4696,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2019-03-08T05:00:00Z,2019,3,2019-03-08T05:00:00Z,,2019-03-08T13:03:38Z,,0,0,0900006483acd653
FDA-2015-E-4696-0007,FDA,FDA-2015-E-4696,"Determination of Regulatory Review Period for Purposes of Patent
Extension; ESBRIET",Notice,Determinations,2018-02-22T05:00:00Z,2018,2,2018-02-22T05:00:00Z,2018-04-24T03:59:59Z,2018-04-25T01:04:20Z,2018-03612,0,0,0900006482f53b4a
FDA-2015-E-4696-0006,FDA,FDA-2015-E-4696,Regulatory Review Letter,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T22:08:36Z,,0,0,09000064825af66a
FDA-2015-E-4696-0005,FDA,FDA-2015-E-4696,Letter from CDER to U.S. Patent and Trademark Office,Other,Letter(s),2017-05-12T04:00:00Z,2017,5,2017-05-12T04:00:00Z,,2017-05-12T18:45:20Z,,0,0,09000064825ae2e0
FDA-2015-E-4696-0004,FDA,FDA-2015-E-4696,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2016-12-23T05:00:00Z,2016,12,2016-12-23T05:00:00Z,,2016-12-23T16:17:02Z,,0,0,0900006482434331
FDA-2015-E-4696-0003,FDA,FDA-2015-E-4696,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-01-26T05:00:00Z,2016,1,2016-01-26T05:00:00Z,,2016-01-26T13:48:42Z,,0,0,0900006481e252e3
FDA-2015-E-4696-0002,FDA,FDA-2015-E-4696,Letter from U.S. Patent and Trademark Office,Other,Letter(s),2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-09T15:42:48Z,,0,0,0900006481d92b75
FDA-2015-E-4696-0001,FDA,FDA-2015-E-4696,"Patent Extension Application from Marshall, Gerstein, & Borun LLP (on behalf of InterMune, Inc.)",Other,Application,2015-12-09T05:00:00Z,2015,12,2015-12-09T05:00:00Z,,2015-12-10T13:32:59Z,,0,0,0900006481d92a8e